Crossmark

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX

Crossref DOI link: https://doi.org/10.1186/s12915-018-0576-6

Published Online: 2018-10-02

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bonin, Florian

Taouis, Karim

Azorin, Paula

Petitalot, Ambre

Tariq, Zakia

Nola, Sebastien

Bouteille, Nadège

Tury, Sandrine

Vacher, Sophie

Bièche, Ivan

Rais, Khadija Ait

Pierron, Gaelle

Fuhrmann, Laetitia

Vincent-Salomon, Anne

Formstecher, Etienne

Camonis, Jacques

Lidereau, Rosette

Lallemand, François https://orcid.org/0000-0001-6336-2285
Driouch, Keltouma
Funding

Funding for this research was provided by:

Breast Cancer Research Foundation (BCRF-16-096)

Gefluc

Ligue Contre le Cancer (2FI10655MMGF)
License Information

Text and Data Mining valid from 2018-10-02
More Information

Article History

Received: 14 March 2018

Accepted: 14 September 2018

First Online: 2 October 2018

Ethics approval and consent to participate

: The study was performed in accordance with the French Bioethics Law 2004–800 and the French National Institute of Cancer (INCa) Ethics Charter and after approval by the Institut Curie review board and ethics committee (Comité de Pilotage du Groupe Sein), which waived the need for written informed consent from the participants. Women were informed of the research use of their tissues and did not declare any opposition to the research.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.